SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics ” or the “Company ”), a clinical-stage immunotherapy company developing pelareorep, today provided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results